Editing CSL Limited (section)

=== COVID-19 pandemic ===
{{See also|COVID-19 pandemic in Australia}}
On 7 September 2020, CSL signed agreements with the Australian government to supply the University of Queensland vaccine ([[V451 vaccine|V451]]) and to manufacture (with [[AstraZeneca]]) the [[University of Oxford|Oxford University]] vaccine ([[AZD1222]]), which would yield nearly 85 million doses for Australians. The agreement was contingent on the future success of clinical trials of these vaccines. Most of the manufacture would occur in Melbourne, Australia.<ref>{{Cite web|date=7 September 2020|title=CSL to manufacture and supply University of Queensland and Oxford University vaccine candidates for Australia|url=https://www.csl.com/news/2020/20200907-csl-to-manufacture-and-supply-uq-and-ou-vaccine-candidates-for-australia|access-date=2020-09-07|website=csl.com|language=en-US}}</ref><ref>{{Cite web|date=7 September 2020|title=Australia secures onshore manufacturing agreements for two COVID-19 vaccines {{!}} Prime Minister of Australia|url=https://www.pm.gov.au/media/australia-secures-onshore-manufacturing-agreements-two-covid-19-vaccines|access-date=2020-09-07|website=pm.gov.au|archive-date=7 September 2020|archive-url=https://web.archive.org/web/20200907043720/https://www.pm.gov.au/media/australia-secures-onshore-manufacturing-agreements-two-covid-19-vaccines|url-status=dead}}</ref>

On 11 December 2020, after a high percentage of the University of Queensland vaccine trial participants returned "false positive" results for HIV, it was decided that vaccine development will not proceed to Phase 2/3 trials.<ref>{{Cite web|title=Update on The University of Queensland COVID-19 vaccine|url=https://wcsecure.weblink.com.au/pdf/CSL/02320942.pdf|publisher=CSL Limited|url-status=live|archive-url=https://web.archive.org/web/20201211104422/https://wcsecure.weblink.com.au/pdf/CSL/02320942.pdf |archive-date=11 December 2020 }}</ref>

On 23 March 2021, the [[Therapeutic Goods Administration]] provisionally approved the first batches, numbering 832,000 doses, of the [[Oxford–AstraZeneca COVID-19 vaccine]] manufactured by CSL in its plant in [[Broadmeadows, Victoria]]. The Australian Government has contracted CSL to produce 50 million doses of the vaccine.<ref>{{Cite web|date=2021-03-23|title=National medical regulator approves 800,000 Australian-made doses of AstraZeneca vaccine|url=https://www.abc.net.au/news/2021-03-23/therapeutic-goods-administration-astrazeneca-vaccine-approved/100024730|access-date=2021-04-09|publisher=Australian Broadcasting Corporation|language=en-AU}}</ref>